An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancer

Jayanthi Vijayakumar, Tufia Haddad, Kalpna Gupta, Janet Sauers, Douglas Yee

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology